Therapeutic agents II
    2.
    发明申请
    Therapeutic agents II 审中-公开
    治疗剂二

    公开(公告)号:US20070185119A1

    公开(公告)日:2007-08-09

    申请号:US10596995

    申请日:2005-01-05

    摘要: Compounds of Formula (I) as well as optical isomers and racemates thereof as well as pharmaceutically acceptable salts, thereof, processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.

    摘要翻译: 式(I)化合物及其旋光异构体及其外消旋物及其药学上可接受的盐,其制备方法,用于治疗肥胖症,精神疾病,认知障碍,记忆障碍,精神分裂症,癫痫, 和相关病症,以及诸如痴呆,多发性硬化症,帕金森病,亨廷顿氏舞蹈病和阿尔茨海默病以及疼痛相关疾病的神经障碍以及含有它们的药物组合物。

    Thienopyrimidine compounds and uses thereof
    8.
    发明授权
    Thienopyrimidine compounds and uses thereof 失效
    噻吩并嘧啶化合物及其用途

    公开(公告)号:US07723331B2

    公开(公告)日:2010-05-25

    申请号:US11840382

    申请日:2007-08-17

    CPC分类号: C07D495/04

    摘要: The present invention provides compounds of the class of thienopyrimidines, processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, type II diabetes, Metabolic syndrome and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea, Alzheimer's disease, and pain related disorders, and to pharmaceutical compositions containing them.

    摘要翻译: 本发明提供噻吩并嘧啶类化合物,制备这些化合物的方法,其用于治疗肥胖症,精神疾病,认知障碍,记忆障碍,精神分裂症,癫痫和相关病症,II型糖尿病,代谢综合征和神经系统疾病 障碍,例如痴呆,多发性硬化,帕金森病,亨廷顿氏舞蹈病,阿尔茨海默病和疼痛相关疾病,以及含有它们的药物组合物。